Search

Your search keyword '"Gynecologists"' showing total 1,441 results
Start Over Author "Gynecologists"

Refine your results

more »

more »

more »

more »

more »

more »
1,441 results on '"Gynecologists"'

7. Medication Abortion Up to 70 Days of Gestation: ACOG Practice Bulletin, Number 225.

Author

American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology, Society of Family Planning

Subjects
Reproductive Medicine, Biomedical and Clinical Sciences, Reproductive health and childbirth, Good Health and Well Being, Abortifacient Agents, Abortion, Induced, Clinical Protocols, Female, Gestational Age, Humans, Mifepristone, Misoprostol, Pregnancy, Pregnancy Trimester, First, United States, American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology, Society of Family Planning, Paediatrics and Reproductive Medicine, Obstetrics & Reproductive Medicine, Reproductive medicine
Abstract

Medication abortion, also referred to as medical abortion, is a safe and effective method of providing abortion. Medication abortion involves the use of medicines rather than uterine aspiration to induce an abortion. The U.S. Food and Drug Administration (FDA)-approved medication abortion regimen includes mifepristone and misoprostol. The purpose of this document is to provide updated evidence-based guidance on the provision of medication abortion up to 70 days (or 10 weeks) of gestation. Information about medication abortion after 70 days of gestation is provided in other ACOG publications ().

Published
2020

12. Clinical characteristics of pregnant women with COVID-19 in Japan: a nationwide questionnaire survey

Author

Tatsuya Arakaki, Junichi Hasegawa, Akihiko Sekizawa, Tomoaki Ikeda, Isamu Ishiwata, Katsuyuki Kinoshita, and the Japan Association of Obstetricians and Gynecologists (JAOG)

Subjects
COVID-19, Pregnancy, Delivery, Gynecology and obstetrics, RG1-991
Abstract

Abstract Background Few reports have presented an overall view of pregnant women with coronavirus disease 2019 (COVID-19) across an entire country and throughout the entire gestation period. Furthermore, no such reports are available for Japan. We examined the clinical characteristics and outcomes of pregnant women with COVID‑19 on a national scale in Japan. Methods A nationwide questionnaire-based survey for all 2,185 maternity services in Japan was conducted between July and August 2020. Information regarding maternal characteristics and epidemiological, clinical, treatment, and perinatal outcomes of pregnant women diagnosed with COVID-19 between 16 January and 30 June 2020 were collected. Main outcome measures were incidence of pregnant women with COVID-19 and infant infection, positive rate of the universal screening test for asymptomatic pregnant women, identification of infection route and rates of maternal death, and severe cases. Results Responses from 1,418 institutions were assessed (65% of all delivery institutions in Japan). Seventy-two pregnant women were reported to have been diagnosed with COVID-19. The positive rate of the universal screening test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among asymptomatic pregnant women was 0.03% (2/7428). The most common route of infection was familial (57%). Fifty-eight pregnant women with COVID-19 were symptomatic, of whom five (8.6%) had a severe infection and one died (a tourist). Severe respiratory symptoms, oxygen administration, and pneumonia were frequently reported in the third trimester and postpartum period compared with in early pregnancy (22.2% vs 2.5% [P = 0.03], 38.9% vs 7.5% [P = 0.01], and 50.0% vs 7.5% [P

Published
2021
Full Text
View/download PDF

13. Treating Prediabetes in the First Trimester

Author

American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine, and Hilary Roeder, MD, Physican, Clinical Instructor, Maternal-Fetal Medicine

Published
2018

15. Osteopathic Manipulative Medicine in Pregnancy: Physiologic and Clinical Effects

Author

National Center for Complementary and Integrative Health (NCCIH), American Osteopathic Association, American Academy of Osteopathy, Med Ed Foundation of the Am Coll of Osteopathic Obstetricians & Gynecologists, Osteopathic Heritage Foundations, and Kendi Hensel, DO, PhD, Associate Professor

Published
2018

18. Project TENDR: Targeting Environmental Neuro-Developmental Risks The TENDR Consensus Statement.

Author

Bennett, Deborah, Bellinger, David C, Birnbaum, Linda S, Bradman, Asa, Chen, Aimin, Cory-Slechta, Deborah A, Engel, Stephanie M, Fallin, M Daniele, Halladay, Alycia, Hauser, Russ, Hertz-Picciotto, Irva, Kwiatkowski, Carol F, Lanphear, Bruce P, Marquez, Emily, Marty, Melanie, McPartland, Jennifer, Newschaffer, Craig J, Payne-Sturges, Devon, Patisaul, Heather B, Perera, Frederica P, Ritz, Beate, Sass, Jennifer, Schantz, Susan L, Webster, Thomas F, Whyatt, Robin M, Woodruff, Tracey J, Zoeller, R Thomas, Anderko, Laura, Campbell, Carla, Conry, Jeanne A, DeNicola, Nathaniel, Gould, Robert M, Hirtz, Deborah, Huffling, Katie, Landrigan, Philip J, Lavin, Arthur, Miller, Mark, Mitchell, Mark A, Rubin, Leslie, Schettler, Ted, Tran, Ho Luong, Acosta, Annie, Brody, Charlotte, Miller, Elise, Miller, Pamela, Swanson, Maureen, Witherspoon, Nsedu Obot, American College of Obstetricians and Gynecologists (ACOG), Child Neurology Society, Endocrine Society, International Neurotoxicology Association, International Society for Children’s Health and the Environment, International Society for Environmental Epidemiology, National Council of Asian Pacific Islander Physicians, National Hispanic Medical Association, and National Medical Association

Subjects
American College of Obstetricians and Gynecologists, Child Neurology Society, Endocrine Society, International Neurotoxicology Association, International Society for Children’s Health and the Environment, International Society for Environmental Epidemiology, National Council of Asian Pacific Islander Physicians, National Hispanic Medical Association, National Medical Association, Humans, Risk Assessment, Developmental Disabilities, Environmental Health, Public Health, Environmental Exposure, Child, United States, Neurodevelopmental Disorders, Behavioral and Social Science, Intellectual and Developmental Disabilities (IDD), Clinical Research, Brain Disorders, Pediatric Research Initiative, Pediatric, Neurosciences, Prevention, Autism, Mental Health, 2.2 Factors relating to the physical environment, Mental health, Toxicology, Environmental Sciences, Medical and Health Sciences
Abstract

Children in America today are at an unacceptably high risk of developing neurodevelopmental disorders that affect the brain and nervous system including autism, attention deficit hyperactivity disorder, intellectual disabilities, and other learning and behavioral disabilities. These are complex disorders with multiple causes—genetic, social, and environmental. The contribution of toxic chemicals to these disorders can be prevented. Approach: Leading scientific and medical experts, along with children’s health advocates, came together in 2015 under the auspices of Project TENDR: Targeting Environmental Neuro-Developmental Risks to issue a call to action to reduce widespread exposures to chemicals that interfere with fetal and children’s brain development. Based on the available scientific evidence, the TENDR authors have identified prime examples of toxic chemicals and pollutants that increase children’s risks for neurodevelopmental disorders. These include chemicals that are used extensively in consumer products and that have become widespread in the environment. Some are chemicals to which children and pregnant women are regularly exposed, and they are detected in the bodies of virtually all Americans in national surveys conducted by the U.S. Centers for Disease Control and Prevention. The vast majority of chemicals in industrial and consumer products undergo almost no testing for developmental neurotoxicity or other health effects. Conclusion: Based on these findings, we assert that the current system in the United States for evaluating scientific evidence and making health-based decisions about environmental chemicals is fundamentally broken. To help reduce the unacceptably high prevalence of neurodevelopmental disorders in our children, we must eliminate or significantly reduce exposures to chemicals that contribute to these conditions. We must adopt a new framework for assessing chemicals that have the potential to disrupt brain development and prevent the use of those that may pose a risk. This consensus statement lays the foundation for developing recommendations to monitor, assess, and reduce exposures to neurotoxic chemicals. These measures are urgently needed if we are to protect healthy brain development so that current and future generations can reach their fullest potential.

Published
2016

23. Current status of community-acquired infection of COVID-19 in delivery facilities in Japan.

Author

Junichi Hasegawa, Tatsuya Arakaki, Akihiko Sekizawa, Tomoaki Ikeda, Isamu Ishiwata, Katsuyuki Kinoshita, and department of medical safety, the Japan Association of Obstetricians and Gynecologists (JAOG)

Subjects
Medicine, Science
Abstract

A nationwide questionnaire survey about community-acquired infection of coronavirus disease 2019 (COVID-19) was conducted in July 2020 to identify the characteristics of and measures taken by Japanese medical facilities providing maternity services. A case-control study was conducted by including medical facilities with (Cases) and without (Control) community-acquired infection of COVID-19. Responses from 711 hospitals and 707 private clinics were assessed (72% of all hospital and 59% all private clinics provided maternity service in Japan). Seventy-five COVID-19-positive pregnant women were treated in 52 facilities. Community-acquired infection was reported in 4.1% of the facilities. Of these, 95% occurred in the hospital. Nine patients developed a community-acquired infection in the maternity ward or obstetric department. Variables that associated with community-acquired infection of COVID-19 (adjusted odds ratio [95% confidence interval]) were found to be state of emergency prefecture (4.93 [2.17-11.16]), PCR test for SARS-CoV-2 on admission (2.88 [1.59-5.24]), and facility that cannot treat COVID-19 positive patients (0.34 [0.14-0.82]). In conclusion, community-acquired infection is likely to occur in large hospitals that treat a higher number of patients than private clinics do, regardless of the preventive measures used.

Published
2021
Full Text
View/download PDF

26. Minimum Knowledge and Skills Objectives for Alcohol and Other Drug Abuse Teaching.

Author

American Psychiatric Association, Hartford, CT., Society of Teachers of Family Medicine, Kansas city, MO., American Coll. of Obstetricians and Gynecologists, Washington, DC., Society of General Internal Medicine., American Coll. of Emergency Physicians, Dallas, TX., and Ambulatory Pediatric Association.

Abstract

This publication brings together statements concerning the minimum knowledge and skills objectives in alcohol and other drug abuse determined by the professional organizations of six medical specialties: pediatrics; emergency medicine; obstetrics and gynecology; psychiatry; general internal medicine; and family medicine for undergraduate, residency, and continuing medical education. It is noted that all six specialties found a need for increased faculty expertise in alcohol and other drug abuse teaching and for the incorporation of clinical skills development within the teaching program. Each statement lists the knowledge and skills objectives and the members of the advisory committee who formulated each statement. (JB)

Published
1991

27. Strategies for preventing group B streptococcal infections in newborns: a nation-wide survey of Italian policies

Author

Chryssoula Tzialla, Alberto Berardi, Claudio Farina, Pierangelo Clerici, Alessandro Borghesi, Elsa Viora, Paolo Scollo, Mauro Stronati, Task Force for group B streptococcal infections for the Italian Society of Neonatology, Italian Society of Obstetricians and Gynecologists, and Italian Association of Clinical Microbiologists

Subjects
Group B streptococcus, GBS, Survey, Infection, Neonate, Newborn infant, Pediatrics, RJ1-570
Abstract

Abstract Background There are no Italian data regarding the strategies for preventing neonatal group B streptococcal (GBS) infection. We conducted a national survey in order to explore obstetrical, neonatal and microbiological practices for the GBS prevention. Methods Three distinct questionnaires were sent to obstetricians, neonatologists and microbiologists. Questionnaires included data on prenatal GBS screening, maternal risk factors, intrapartum antibiotic prophylaxis, microbiological information concerning specimen processing and GBS antimicrobial susceptibility. Results All respondent obstetrical units used the culture-based screening approach to identify women who should receive intrapartum antibiotic prophylaxis, and more than half of the microbiological laboratories (58%) reported using specimen processing consistent with CDC guidelines. Most neonatal units (89 out of 107, 82%) reported using protocols for preventing GBS early-onset sepsis consistent with CDC guidelines. Conclusions The screening-based strategy is largely prevalent in Italy, and most protocols for preventing GBS early-onset sepsis are consistent with CDC guidelines. However, we found discrepancies in practices among centers that may reflect the lack of Italian guidelines issued by public health organizations.

Published
2017
Full Text
View/download PDF

29. Increasing Access to Abortion

Author

Gynecologists’ Abortion Access

Subjects
Economic growth, Medically Underserved Area, Stigma (botany), Abortion, Health Services Accessibility, 03 medical and health sciences, 0302 clinical medicine, Pregnancy, Health care, Humans, Medicine, 030212 general & internal medicine, reproductive and urinary physiology, Reproductive health, Government, 030219 obstetrics & reproductive medicine, business.industry, Obstetrics and Gynecology, Abortion, Induced, Legislature, United States, Obstetrics, embryonic structures, Women's Health, Female, Legal abortion, Rural area, business
Abstract

Individuals require access to safe, legal abortion. Abortion, although legal, is increasingly out of reach because of numerous restrictions imposed by the government that target patients seeking abortion and their health care practitioners. Insurance coverage restrictions, which take many forms, constitute a substantial barrier to abortion access and increase reproductive health inequities. Adolescents, people of color, those living in rural areas, those with low incomes, and incarcerated people can face disproportionate effects of restrictions on abortion access. Stigma and fear of violence may be less tangible than legislative and financial restrictions, but are powerful barriers to abortion provision nonetheless. The American College of Obstetricians and Gynecologists, along with other medical organizations, opposes such interference with the patient-clinician relationship, affirming the importance of this relationship in the provision of high-quality medical care. This revision includes updates based on new restrictions and litigation related to abortion.

Published
2020
Full Text
View/download PDF

30. Immunization for Pregnant Women: A Call to Action

Author

Neonatal Nurses, Maureen G. Phipps, John Cullen, Rebecca Cypher, Susan Stone, and Gynecologists

Subjects
Adult, Pregnancy, medicine.medical_specialty, business.industry, Vaccination, MEDLINE, Obstetrics and Gynecology, Prenatal Care, medicine.disease, Critical Care Nursing, Pediatrics, United States, Call to action, Immunization, Family medicine, Maternity and Midwifery, medicine, Humans, Female, Pregnant Women, Centers for Disease Control and Prevention, U.S, business
Published
2020
Full Text
View/download PDF

31. Obstetric Care Consensus #10: Management of Stillbirth

Author

Uma M Reddy, Ruth C Fretts, Gynecologists, Mark Turrentine, Torri D Metz, and Rana Snipe Berry

Subjects
Pregnancy, medicine.medical_specialty, Assisted reproductive technology, Referral, business.industry, Obstetrics, medicine.medical_treatment, media_common.quotation_subject, Obstetrics and Gynecology, Gestational age, Peer support, medicine.disease, Health care, medicine, Grief, Advanced maternal age, business, reproductive and urinary physiology, media_common
Abstract

Stillbirth is one of the most common adverse pregnancy outcomes, occurring in 1 in 160 deliveries in the United States. In developed countries, the most prevalent risk factors associated with stillbirth are non-Hispanic black race, nulliparity, advanced maternal age, obesity, preexisting diabetes, chronic hypertension, smoking, alcohol use, having a pregnancy using assisted reproductive technology, multiple gestation, male fetal sex, unmarried status, and past obstetric history. Although some of these factors may be modifiable (such as smoking), many are not. The study of specific causes of stillbirth has been hampered by the lack of uniform protocols to evaluate and classify stillbirths and by decreasing autopsy rates. In any specific case, it may be difficult to assign a definite cause to a stillbirth. A significant proportion of stillbirths remains unexplained, even after a thorough evaluation. Evaluation of a stillbirth should include fetal autopsy; gross and histologic examination of the placenta, umbilical cord, and membranes; and genetic evaluation. The method and timing of delivery after a stillbirth depend on the gestational age at which the death occurred, maternal obstetric history (eg, previous hysterotomy), and maternal preference. Health care providers should weigh the risks and benefits of each strategy in a given clinical scenario and consider available institutional expertise. Patient support should include emotional support and clear communication of test results. Referral to a bereavement counselor, peer support group, or mental health professional may be advisable for management of grief and depression.

Published
2020
Full Text
View/download PDF

32. 2023 OB/GYN Coding Manual : Components of Correct Coding

Author

American College of Obstetricians & Gynecologists, American College of Obstetricians & Gynecologists ACOG, American College of Obstetricians & Gynecologists, and American College of Obstetricians & Gynecologists ACOG

Subjects
Obstetrics--Standards, Gynecology--Standards
Abstract

The 2023 OB/GYN Coding Manual: Components of Correct Coding is now available! The updated 2023 OB/GYN Coding Manual has been modified with input from physicians and coders to improve ease of use and provide unique information just for ob-gyn practices. The 2023 version includes: EW codes for inpatient, observations, consultations, and emergency department visits • Coding tips and scenarios for key ob-gyn surgery codes, directly pulled from questions submitted from ACOG's Payment Advocacy and Policy Portal (acogcoding.freshdesk.com). • Updated chapters on evaluation and management code selection and vaccine administration, with reference charts outlining the new codes • Updated, printable, one-page charts for easy desk reference relevant for 2023

Published
2022

33. Birth Control : Choosing a Method That’s Right for You

Author

American College of Obstetricians and Gynecologists Obstetricians and Gynecologists and American College of Obstetricians and Gynecologists Obstetricians and Gynecologists

Subjects
Birth control
Abstract

This booklet can help you make informed decisions about your birth control choices. Each method of birth control is covered, including how it works, how to use it, and the health benefits and effectiveness rates.

Published
2021

34. 2021 OB/GYN Coding Manual: Components of Correct Procedural Coding

Author

American College of Gynecologists and Obstetricians, American College of Obstetricians & Gynecologists ACOG, American College of Gynecologists and Obstetricians, and American College of Obstetricians & Gynecologists ACOG

Subjects
Obstetrics--Standards, Gynecology--Standards
Abstract

The 2021 OB/GYN Coding Manual: Components of Correct Procedural Coding is now available. Coding errors can delay payment, lead to increased denials, and even federal penalties. Ensure that your practice is coding accurately and getting reimbursed efficiently—purchase this essential resource today!ACOG's OB/GYN Coding Manual is the primary billing and coding resource for obstetricians, gynecologists, and their staff. The 2021 expanded edition incorporates instruction from our Procedural Coding for Obstetricians and Gynecologists booklet and includes new sections on Evaluation and Management, Telehealth, and COVID-19.The coding material, which is organized by systems, offers 2021 updates that can be used for billing, preauthorization requirements, appeals, and more. The Appendices include printable tables for the quick reference of the coding guidelines in this manual.The manual follows established CPT guidelines and includes Medicare guideline information for accurately reporting medical procedures. It represents the expert opinions of ACOG staff and members of the ACOG Committee on Health Economics and Coding (CHEC) about the specific services included (or not included) in each ob-gyn procedure code listed.Text and guidance are based on the following:The CPT code vignettes and relative value units (RVUs)Definitions of the global surgical packageBundling rules for global surgical packagesExceptions to the global package bundling rulesCPT's global obstetric packageOrder the 2021 OB/GYN Coding Manual today.

Published
2021

36. Obstetric Care Consensus #9: Levels of Maternal Care

Author

William M. Callaghan, Prevention’s, Sarah J. Kilpatrick, M. Kathryn Menard, Gynecologists, Neonatal Nurses, and Christopher M. Zahn

Subjects
Pregnancy, medicine.medical_specialty, education.field_of_study, 030219 obstetrics & reproductive medicine, business.industry, Population, Specialty, Obstetrics and Gynecology, Disease, Subspecialty, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, Family medicine, Health care, Medicine, Professional association, 030212 general & internal medicine, business, education, Accreditation
Abstract

Maternal mortality and severe maternal morbidity, particularly among women of color, have increased in the United States. The leading medical causes of maternal mortality include cardiovascular disease, infection, and common obstetric complications such as hemorrhage and vary by timing relative to the end of pregnancy. Although specific modifications in the clinical management of some of these conditions have been instituted, more can be done to improve the system of care for high-risk women at facility and population levels. The goal of levels of maternal care is to reduce maternal morbidity and mortality, including existing disparities, by encouraging the growth and maturation of systems for the provision of risk-appropriate care specific to maternal health needs. To standardize a complete and integrated system of perinatal regionalization and risk-appropriate maternal care, this classification system establishes levels of maternal care that pertain to basic care (level I), specialty care (level II), subspecialty care (level III), and regional perinatal health care centers (level IV). The determination of the appropriate level of care to be provided by a given facility should be guided by regional and state health care entities, national accreditation and professional organization guidelines, identified regional perinatal health care service needs, and regional resources. State and regional authorities should work together with the multiple institutions within a region, and with the input from their obstetric care providers, to determine the appropriate coordinated system of care and to implement policies that promote and support a regionalized system of care. These relationships enhance the ability of women to give birth safely in their communities while providing support for circumstances when higher level resources are needed. This document is a revision of the original 2015 Levels of Maternal Care Obstetric Care Consensus, which has been revised primarily to clarify terminology and to include more recent data based on published literature and feedback from levels of maternal care implementation.

Published
2019
Full Text
View/download PDF

37. Pelvic Organ Prolapse

Author

Gynecologists

Subjects
Benign condition, Population ageing, medicine.medical_specialty, genetic structures, Urology, behavioral disciplines and activities, Pelvic Organ Prolapse, Gynecologic Surgical Procedures, Quality of life, Risk Factors, medicine, Humans, Pelvic organ, urogenital system, business.industry, Obstetrics, Incidence (epidemiology), Obstetrics and Gynecology, Surgical Mesh, United States, body regions, Sexual dysfunction, Surgical mesh, Female, Surgery, Lifetime risk, medicine.symptom, business
Abstract

Pelvic organ prolapse (POP) is a common, benign condition in women. For many women, it can cause vaginal bulge and pressure, voiding dysfunction, defecatory dysfunction, and sexual dysfunction, which may adversely affect quality of life. Women in the United States have a 13% lifetime risk of undergoing surgery for POP. Although POP can occur in younger women, the peak incidence of POP symptoms is in women aged 70 to 79 years. Given the aging population in the United States, it is anticipated that by 2050 the number of women experiencing POP will increase by approximately 50%. The purpose of this joint document of the American College of Obstetricians and Gynecologists and the American Urogynecologic Society is to review information on the current understanding of POP in women and to outline guidelines for diagnosis and management that are consistent with the best available scientific evidence.

Published
2019
Full Text
View/download PDF

38. Ethical Approach for Managing Patient-Physician Conflict and Ending the Patient-Physician Relationship: ACOG Committee Statement No. 3.

Author

American College of Obstetrician and Gynecologists’ Committee on Ethics

Subjects
*PHYSICIAN-patient relations, *CONFLICT management, *PATIENT-professional relations, *THERAPEUTIC alliance, *PHYSICIANS
Abstract

Physicians have an ethical obligation to foster a therapeutic alliance with their patients. If the therapeutic relationship becomes strained, physicians should attempt to resolve the conflict, when possible, through intentional patient-physician discussion or through a third-party mediator. If return to a therapeutic relationship is not possible or mutually desirable, ending the patient-physician relationship may be the best option for the patient and the physician. This Committee Statement provides an ethical framework for managing patient-physician conflict and evidence-based tools and interpersonal interventions to help rebuild meaningful connection with patients. Guidance for the ethical termination of care when the therapeutic alliance cannot be restored also is provided, including institutional responsibilities to patients and physicians. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

39. 2024 OB/GYN Coding Manual : Components of Correct Coding

Author

American College of Obstetricians and Gynecologists ACOG and American College of Obstetricians and Gynecologists ACOG

Subjects
Medical fees
Abstract

The 2024 OB/GYN Coding Manual: Components of Correct Coding is the primary billing and coding resource for obstetrician–gynecologists and their staff. For 2024, the manual has been modified with input from physicians and coders to improve ease of use and provide unique billing information just for ob-gyn practices. The coding material, which is organized by systems, offers 2024 updates that can be used for billing, coding, preauthorization requirements, claims appeals, and more. The appendices include tables for the quick reference of the coding guidelines in this manual. Updates in the 2024 version include: •New codes for transcervical radiofrequency ablation of uterine fibroids •New codes for hyperthermic intraperitoneal chemotherapy •New evaluation and management codes for pelvic exam •Significant new category III codes added to the list of temporary codes for reporting emerging technology, services, and procedures •Significant additions to the neurostimulator codes •New time ranges for office or other outpatient visit codes to align with other evaluation and management codes

Published
2024

40. PROLOG: Gynecology and Surgery, Ninth Edition (Assessment & Critique)

Author

American College of Obstetricians & Gynecologists and American College of Obstetricians & Gynecologists

Subjects
Generative organs, Female--Surgery
Abstract

PROLOG: Gynecology and Surgery, Ninth Edition, is the premier resource for staying up to date in this specialty area. Consisting of critique and assessment sections, PROLOG offers an effective, self-directed study experience for obstetrician - gynecologists and those in training. The content is current, relevant, and written and reviewed by experts in the field. Put your knowledge to the test and earn 25 CME credits with this volume. Upon completing PROLOG: Gynecology and Surgery, Ninth Edition, learners should be able to:• Establish a differential diagnosis and screen patients with appropriate diagnostic tests for specific gynecologic conditions.• Determine the appropriate medical management for specific gynecologic conditions in adolescents, adult women, and all people seeking obstetric and gynecologic care.• Identify appropriate surgical interventions for various gynecologic conditions and strategies to prevent and treat surgical complications.• Apply the concepts of anatomy, genetics, pathophysiology, and epidemiology to the understanding of diseases that affect adolescents, women and all people seeking obstetric and gynecologic care.• Counsel patients regarding treatment options and adjustment to crises that may alter their lifestyles.• Apply professional medical ethics and the understanding of medical - legal issues relative to the practice of gynecology.Order PROLOG: Gynecology and Surgery, Ninth Edition today! A complimentary, online study tool— PROLOG Games— is included with purchase of this print copy.

Published
2024

41. PROLOG: Obstetrics, Ninth Edition (Assessment & Critique)

Author

College of American, American College of Obstetricians & Gynecologists, College of American, and American College of Obstetricians & Gynecologists

Subjects
Obstetrics--Examinations, questions, etc
Abstract

PROLOG: Obstetrics is the premier learning tool for staying up to date in the specialty area. Consisting of an assessment and critique book, PROLOG is an effective, self-directed study resource and reference for both obstetricians - gynecologists and those in training. The content is peer-reviewed, current, and clinically relevant. Put your knowledge to the test and earn up to 25 CME credits with this volume.Upon successful completion, users of this unit will be able to:Demonstrate an understanding of maternal and fetal physiology and pathophysiology and the effects on normal and complicated pregnanciesIdentify components of antepartum care that optimize maternal and perinatal outcomes in uncomplicated pregnancies, including education regarding normal pregnancyDiagnose and plan efficacious and cost-effective management of medical and obstetric conditions encountered during the antepartum periodIdentify the risks and prognosis of selected complications of pregnancy and in the neonateDescribe antenatal genetic screening and diagnostic tests and identify the indications, risks, and predictive value for eachDiagnose problems and manage obstetric emergenciesSelect appropriate management strategies for intrapartum care and deliveryConsider medical-legal principles, risk management, and office management guidelines in obstetric practiceOrder PROLOG: Obstetrics, Ninth Edition, today!A complimentary, online study tool— PROLOG Games— is included with purchase of this print copy.

Published
2023

42. Breastfeeding Handbook for Physicians

Author

American Academy of Pediatrics, American College of Obstetricians and Gynecologists (ACOG), Richard Schanler, Lori Feldman-Winter, Joan Younger Meek, Sharon B Mass, Lawrence Noble, American Academy of Pediatrics, American College of Obstetricians and Gynecologists (ACOG), Richard Schanler, Lori Feldman-Winter, Joan Younger Meek, Sharon B Mass, and Lawrence Noble

Subjects
Breastfeeding--Handbooks, manuals, etc, Breastfeeding
Abstract

The Breastfeeding Handbook for Physicians, 3rd Edition, is the definitive resource on breastfeeding initiation, maintenance, support, and advocacy. Jointly developed by the American Academy of Pediatrics (AAP) and The American College of Obstetricians and Gynecologists (ACOG), this must-have handbook features the most important and up-to-date developments in breastfeeding practice, research, policies, and outreach guidance, assembled by an expert physician panel.All health professionals in your practice will refer to this convenient handbook again and again for easily accessible answers, solutions, and teaching and learning aids.The third edition contains a wealth of practice-focused advice based on frontline clinical experience and the latest evidence for breastfeeding.Topics include:Cleft lip and cleft palate in breastfeeding infantsRisk reductions in breastfeeding infantsNeurodevelopmental outcomes of breastfeedingBreastfeeding in preterm infantsHealth benefits of breastfeeding for mothersRecommended breastfeeding strategies for health professionalsBreastfeeding educationRecommended breastfeeding practicesRisk factors for lactation problemsHuman milk microbiota and bioactive factorsBreast development stages and lactogenesisSupporting early breastfeeding before and after deliveryBreastfeeding assessment toolsAnkyloglossia and breastfeedingInsufficient milkVitamin and mineral supplementationBreastfeeding guidance during preventive health care visitsManagement of breastfeeding complicationsElements of a breastfeeding-friendly office environmentNational breastfeeding initiativesFeeding human milk without birthingRelactationSupplemental feeding methodsDrugs and breastfeedingContraception When BreastfeedingAnd more!New in the 3rd EditionThe latest AAP and ACOG breastfeeding policiesAn all-new chapter on the Non-nutritive Components in Human Milk, including bioactive factors and host defense mechanismsNew guidance on breastfeeding and substance use, including electronic cigarettes and alcoholUpdated life-saving breastfeeding support strategies for inclusion in disaster preparedness plansCurrent evidence on infant and maternal outcomes from breastfeedingUpdated guidance on vitamin D, vitamin K, and iron supplementation in newbornsUpdated discussion of breastfeeding and environmental agents, including sunscreenNew guidance for COVID-19 and breastfeedingUpdated discussion of legislative protections for mothers in the workplace

Published
2023

43. Professional Relationships With Industry: ACOG Committee Statement No. 2.

Author

American College of Obstetricians and Gynecologists’ Committee on Ethics

Subjects
*PROFESSIONAL relationships, *GYNECOLOGISTS, *EDUCATIONAL objectives, *PHARMACEUTICAL industry, *MEDICAL equipment, *EDUCATORS, *INDUSTRIES, *CONFLICT of interests, *DRUGS, *PHYSICIANS, *ENDOWMENTS, *MEDICAL research
Abstract

Developers and manufacturers of pharmaceutical agents and medical devices assist physicians in the pursuit of their educational goals and objectives through financial support of various medical, research, and educational programs. In general, industry seeks to optimize profit by providing useful goods and services. However, industry priorities may not always align with the ethical responsibilities of clinicians to promote the best interests of their patients, of educators to provide evidence-based instruction, and of researchers to ensure the scientific integrity of their investigations. To minimize both actual and perceived conflicts of interest, physicians and institutions should set guidelines for themselves and their employees regarding acceptable interaction with industry representatives. In this Committee Statement, the American College of Obstetricians and Gynecologists' Committee on Ethics provides recommendations for the management of professional relationships with industry, with an updated literature review and discussion of prevalence, regulations, and the effects of industry involvement in clinical care, education, and research. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

44. General Approaches to Medical Management of Menstrual Suppression: ACOG Clinical Consensus No. 3.

Author

American College of Obstetricians and Gynecologists’ Committee on Clinical Consensus–Gynecology

Subjects
*LEVONORGESTREL intrauterine contraceptives, *HEALTH services accessibility, *PATIENT autonomy, *PATIENT preferences, *ORAL contraceptives
Abstract

Summary: The purpose of this document is to review currently available management options, general principles, and counseling approaches for reproductive-aged patients requesting menstrual suppression. It includes considerations for unique populations, including adolescents, patients with physical or cognitive disabilities or both, and those with limited access to health care. Gynecologists should be familiar with the use of hormonal therapy for menstrual suppression (including combined oral contraceptive pills, combined hormonal patches, vaginal rings, progestin-only pills, depot medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine device, and the etonogestrel implant). Approaches to counseling should be individualized based on patient preferences and goals, average treatment effectiveness, and contraindications or risk factors for adverse events. Counseling regarding the choice of hormonal medication for menstrual suppression should be approached with the utmost respect for patient autonomy and be free of coercion. Complete amenorrhea may be difficult to achieve; thus, obstetrician-gynecologists and other clinicians should counsel patients and caregivers, if applicable, about realistic expectations. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

45. Current status of community-acquired infection of COVID-19 in delivery facilities in Japan

Author

Akihiko Sekizawa, Tatsuya Arakaki, Isamu Ishiwata, Tomoaki Ikeda, Gynecologists, Junichi Hasegawa, and Katsuyuki Kinoshita

Subjects
RNA viruses, Viral Diseases, Critical Care and Emergency Medicine, Pulmonology, Coronaviruses, Maternal Health, Geographical Locations, Labor and Delivery, 0302 clinical medicine, Medical Conditions, Obstetrics and gynaecology, Japan, Pregnancy, Medicine and Health Sciences, 030212 general & internal medicine, Pregnancy Complications, Infectious, Pathology and laboratory medicine, Virus Testing, Multidisciplinary, Incidence (epidemiology), Incidence, Questionnaire, Obstetrics and Gynecology, Medical microbiology, Community-Acquired Infections, Infectious Diseases, 030220 oncology & carcinogenesis, Viruses, Medicine, Female, SARS CoV 2, Pathogens, Research Article, Adult, medicine.medical_specialty, Asia, Coronavirus disease 2019 (COVID-19), SARS coronavirus, Science, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Microbiology, 03 medical and health sciences, Respiratory Disorders, Diagnostic Medicine, medicine, Humans, Biology and life sciences, business.industry, Organisms, Viral pathogens, COVID-19, Covid 19, Odds ratio, medicine.disease, Confidence interval, Microbial pathogens, Health Care, Health Care Facilities, Emergency medicine, People and Places, Respiratory Infections, Birth, Women's Health, Health Facilities, business
Abstract

A nationwide questionnaire survey about community-acquired infection of coronavirus disease 2019 (COVID-19) was conducted in July 2020 to identify the characteristics of and measures taken by Japanese medical facilities providing maternity services. A case-control study was conducted by including medical facilities with (Cases) and without (Control) community-acquired infection of COVID-19. Responses from 711 hospitals and 707 private clinics were assessed (72% of all hospital and 59% all private clinics provided maternity service in Japan). Seventy-five COVID-19-positive pregnant women were treated in 52 facilities. Community-acquired infection was reported in 4.1% of the facilities. Of these, 95% occurred in the hospital. Nine patients developed a community-acquired infection in the maternity ward or obstetric department. Variables that associated with community-acquired infection of COVID-19 (adjusted odds ratio [95% confidence interval]) were found to be state of emergency prefecture (4.93 [2.17–11.16]), PCR test for SARS-CoV-2 on admission (2.88 [1.59–5.24]), and facility that cannot treat COVID-19 positive patients (0.34 [0.14–0.82]). In conclusion, community-acquired infection is likely to occur in large hospitals that treat a higher number of patients than private clinics do, regardless of the preventive measures used.

Published
2020

46. Human Papillomavirus Vaccination: ACOG Committee Opinion, Number 809

Author

Gynecologists' Immunization

Subjects
Adult, Male, medicine.medical_specialty, Adolescent, Genital Neoplasms, Female, Health Personnel, Advisory Committees, Sexually Transmitted Diseases, HPV vaccines, Genital warts, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Health care, medicine, Humans, 030212 general & internal medicine, Papillomavirus Vaccines, Child, Immunization Schedule, Societies, Medical, 030219 obstetrics & reproductive medicine, business.industry, Incidence (epidemiology), Papillomavirus Infections, Vaccination, HPV infection, virus diseases, Obstetrics and Gynecology, Middle Aged, medicine.disease, female genital diseases and pregnancy complications, Human papillomavirus vaccination, United States, Condylomata Acuminata, Family medicine, Sexual orientation, Genital Neoplasms, Male, Female, Patient Safety, business
Abstract

Human papillomavirus (HPV) causes significant morbidity and mortality in women and men. The HPV vaccine significantly reduces the incidence of anogenital cancer and genital warts in women and in men. Human papillomavirus vaccines are among the most effective vaccines available worldwide, with unequivocal data demonstrating greater than 99% efficacy when administered to women who have not been exposed to that particular type of HPV. Obstetrician-gynecologists and other health care professionals should strongly recommend HPV vaccination to eligible patients and stress the benefits and safety of the HPV vaccine. Further, obstetrician-gynecologists are encouraged to stock and administer HPV vaccines in their offices when feasible. Ideally, the HPV vaccine should be given in early adolescence because vaccination is most effective before exposure to HPV through sexual activity. Unvaccinated women age 26 years and younger should receive the HPV vaccine series regardless of sexual activity, prior exposure to HPV, or sexual orientation. The HPV vaccine is now licensed in the United States for women and men through age 45 years. For some women aged 27-45 years who are previously unvaccinated, obstetrician-gynecologists and other health care professionals may use shared clinical decision making regarding HPV vaccination, considering the patient's risk for acquisition of a new HPV infection and whether the HPV vaccine may provide benefit.

Published
2020

47. Analysis of preventability of hypertensive disorder in pregnancy-related maternal death using the nationwide registration system of maternal deaths in Japan

Author

Hiroaki Tanaka, Masamitsu Nakamura, Jun Yoshimatsu, Masahiko Nakata, Shinji Katsuragi, Isamu Ishiwata, Kazuhiro Osato, Akihiko Sekizawa, Naohiro Kanayama, Takeshi Murakoshi, Junichi Hasegawa, Kayo Tanaka, Gynecologists, and Tomoaki Ikeda

Subjects
Adult, HELLP Syndrome, medicine.medical_specialty, Blood Pressure, Registration system, 030204 cardiovascular system & hematology, Hypertensive disorder, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Japan, Pre-Eclampsia, Pregnancy, medicine, Humans, Eclampsia, Registries, 030219 obstetrics & reproductive medicine, Obstetrics, business.industry, Obstetrics and Gynecology, Hypertension, Pregnancy-Induced, Middle Aged, medicine.disease, Maternal Mortality, Pediatrics, Perinatology and Child Health, Maternal Death, Female, Maternal death, Preventive Medicine, business
Abstract

Objective: Hypertensive disorder of pregnancy (HDP) is a major cause of maternal death. The goal of this study was to investigate factors associated with maternal death due to HDP.Study design: HDP...

Published
2018
Full Text
View/download PDF

48. Infertility and Multiple Miscarriages : Diagnosis, Treatment Options, and How to Cope

Author

American College of Obstetricians and Gynecologists and American College of Obstetricians and Gynecologists

Subjects
Miscarriage, Infertility
Abstract

Infertility is a common problem, and it can happen even if you've been pregnant before. In the United States, as many as 15 in 100 couples have trouble getting pregnant. If you are trying to have a baby and have not gotten pregnant, you and your partner may need an infertility evaluation. Exams and tests can be done to try to find the reason why you and your partner have not gotten pregnant. In this booklet, you'll learn how pregnancy works, some possible causes of infertility and multiple miscarriages, what tests you might need, and what treatments are available.

Published
2022

49. Su Embarazo Y El Nacimiento De Su Bebe : Mes Por Mes

Author

American College of Obstetricians and Gynecologists and American College of Obstetricians and Gynecologists

Subjects
Childbirth--Popular works, Pregnancy--Popular works
Abstract

Take charge of your pregnancy. For trusted advice, turn to Your Pregnancy and Childbirth: Month to Month from the American College of Obstetricians and Gynecologists.This fully revised edition of Your Pregnancy and Childbirth: Month to Month offers the latest medical guidelines in straightforward, easy-to-read language to help you make the best decisions for you and your pregnancy. You can trust that the information you read is supported by medical research and the everyday experience of ob-gyns who have cared for millions of pregnant women. Your Pregnancy and Childbirth encourages you to learn about prepregnancy health and planning, pregnancy, labor and delivery, and the postpartum perioduse the information you learn to talk with your ob-gyn and others who may care for you during pregnancybe an empowered, active decision-maker in your care Medical information has been updated, and new illustrations have been added. A chapter of Frequently Asked Questions also has been added in response to reader feedback. And new for this edition are important tools that you can use when talking with your ob-gyn, including a medical history form to review before your first prenatal care visita form to track possible exposure to toxic or harmful things at home or worka checklist for tracking symptoms or concerns during the postpartum perioda chart to note contact information for friends, family, and health care providers who will help you during the postpartum period Pregnancy is a life-changing experience. Get the answers and support you need from Your Pregnancy and Childbirth: Month to Month.

Published
2022

50. PROLOG: Patient Management in the Office, Eighth Edition

Author

American College of Obstetricians and Gynecologists and American College of Obstetricians and Gynecologists

Subjects
Obstetrics--Examinations, questions, etc, Gynecology--Examinations, questions, etc
Abstract

PROLOG: Patient Management in the Office, Eighth Edition, is the premier learning tool for staying up-to-date in obstetrics and gynecology. Consisting of an assessment and critique book, PROLOG is an effective, self-directed study resource and reference for both obstetrician - gynecologists and those in training. The content is peer-reviewed, current, and clinically relevant. Put your knowledge to the test and earn 25 CME credits with this volume.

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results